Sharmili Balarajah - Concepedia

Author

Sharmili Balarajah

University of Exeter ORCID

Also Known As

D. Symmons, Hemanth Prabhudev, Jonathan W. Lo, S Balarajah, S. Balarajah, Sharmili Balarajah

Publications

608

Citations

H-Index

Concepts

All Affiliations

University of Exeter University of Hull King's College London Barts Health NHS Trust Imperial College London

About

Sharmili Balarajah is an author at University of Exeter specializing in medicine, central nervous system, and neurophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	209
2	Social Sciences	2	2	172
3	Neurology	2	2	172
4	Neuroscience	2	2	172
5	Gastroenterology	1	1	37

Sharmili Balarajah

Publications

455

Citations

H-Index

Page 1

	Year	Citations
Axonally Derived Neuregulin-1 Is Required for Remyelination and Regeneration after Nerve Injury in Adulthood Florence R. Fricker, Natalia Lago, Sharmili Balarajah, Journal of Neuroscience Peripheral Nerve InjuryPeripheral NervePeripheral NervesSocial SciencesNeuroregeneration	2011	154
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim, The Lancet. Gastroenterology & hepatology	2022	147
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study James L. Alexander, Zhigang Liu, Diana Mūnoz Sandoval, The Lancet. Gastroenterology & hepatology	2022	64
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study Shaji Sebastian, G Walker, Nicholas A. Kennedy, The Lancet. Gastroenterology & hepatology Covid-19 PandemicGastroenterologyInfection ControlInterventional EndoscopyUlcerative Colitis	2021	37
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study Zhigang Liu, Kaixing Le, Xin Zhou, The Lancet. Gastroenterology & hepatology	2022	35
The Pathophysiology of Impulse control Disorders in Parkinson Disease Sharmili Balarajah, Andrea E. Cavanna Behavioural Neurology Motor DysfunctionNeurological DisorderClinical NeurologyClinical NeuroscienceSocial Sciences	2013	18

Page 1